News

The company also announced that it has received an additional commitment from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to

Welichem, Celestial and BWTP have been trying to negotiate with the relevant Chinese authorities since 2012 to obtain approval of the China APA as required for the transfer

The Phase I trial, conducted in the US, was an open-label, single-arm, multicentre study, to assess safety, tolerability, and levels of anti-drug antibodies in the patients’ serum. The

The clinical study is being conducted at the University of California, Irvine under the direction of Dr. Virginia Kimonis. "We have found that the support of FPWR extends

The Beijing CDC plans to order a minimum of 1.2 million doses of the seasonal flu vaccine this year from four domestic vaccine manufacturers for its vaccination campaign.

The clinical program will follow protocols developed by a subcommittee made up of representatives of the Pediatric Heart Network (PHN), a multi-center clinical research network funded by the

Also known as MPS II, Hunter syndrome is a rare, severe, progressive and life-limiting lysosomal storage disorder. Under the agreement, Shire receives worldwide commercialization rights for AGT-182. ArmaGen

Under the deal, both the firms will jointly develop and commercialize Opdivo (nivolumab) and Yervoy (ipilimumab) across a broad range of tumor types. Development costs and commercial profits

Currently, Puma is developing PB272 for the treatment of patients with HER2-positive breast cancer as well as for patients with non-small cell lung cancer, breast cancer and other